ClinConnect ClinConnect Logo
Search / Trial NCT05713695

Supporting Treatment Access and Recovery Through Linkage and Support

Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Jan 27, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Co Occurring Disorders Opioid Overdose Mental Health Disorders Substance Use Medication For Opioid Use Disorder (Moud) Peer Support Medication Assisted Treatment (Mat) Healthcare Access Social Determinants Of Health Coordination Of Care Socioecological Model Multi Component Interventions Addiction Equity

ClinConnect Summary

This clinical trial, titled "Supporting Treatment Access and Recovery Through Linkage and Support," is looking to help people who have both mental health disorders and substance use disorders. The study will involve 208 participants over three years and aims to compare two different types of support: one that includes a comprehensive team approach called MISSION and another that offers support through a Peer Specialist. The goal is to see which method better helps individuals improve their treatment engagement, reduce substance use, and enhance their mental health.

To join this trial, you need to be at least 18 years old and have both a substance use disorder (like problems with alcohol or drugs) and a mental health disorder (such as depression or anxiety). Participants should not be receiving other intensive treatments for these issues at the time. If you join, you can expect to receive either the MISSION approach or the Peer Specialist support, and both methods are designed to help you on your path to recovery. It's important to note that individuals who are in an acute crisis, like being very suicidal or needing immediate medical attention, won't be eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Are 18 or older;
  • Have a COD (1 or more substance use disorders (e.g., alcohol and illicit substances), and a mental health disorder (including depression, anxiety, trauma related disorders, bipolar, and/or schizophrenia);
  • Are in the Hub; and
  • Are not engaged in other ongoing multi-component treatment for COD with a behavioral health treatment provider or have not seen their provider for at least 3 months.
  • Exclusion Criteria:
  • We will exclude individuals who are acutely psychotic, acutely suicidal with a plan, or homicidal
  • Or with concurrent severe alcohol use disorder or high dose benzodiazepine requiring detoxification.

About University Of Massachusetts, Worcester

The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.

Locations

Worcester, Massachusetts, United States

Worcester, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

David Smelson, PsyD

Principal Investigator

University of Massachusetts, Worcester

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials